期刊
SCIENTIFIC REPORTS
卷 6, 期 -, 页码 -出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/srep37815
关键词
-
资金
- Kitasato University Medical Center
- MEXT
- Kawano Masanori Memorial Public Interest Incorporated Foundation for Promotion of Pediatrics
- P-DIRECT (Project for Development of Innovative Research on Cancer Therapeutics) grant from The Japan Agency for Medical Research and Development
- SENSHIN Medical Research Foundation
- Grants-in-Aid for Scientific Research [15K06829] Funding Source: KAKEN
Influenza virus (IFV) infection is a common cause of severe pneumonia. Studies have suggested that excessive activation of the host immune system including macrophages is responsible for the severe pathologies mediated by IFV infection. Here, we focused on the X11 protein family member Mint3/Apba3, known to promote ATP production via glycolysis by activating hypoxia inducible factor-1 (HIF-1) in macrophages, and examined its roles in lung pathogenesis and anti-viral defence upon IFV infection. Mint3-deficient mice exhibited improved influenza pneumonia with reduced inflammatory cytokines/chemokine levels and neutrophil infiltration in the IFV-infected lungs without alteration in viral burden, type-I interferon production, or acquired immunity. In macrophages, Mint3 depletion attenuated NF-kappa B signalling and the resultant cytokine/chemokine production in response to IFV infection by increasing I kappa B alpha and activating the cellular energy sensor AMPK, respectively. Thus, Mint3 might represent one of the likely therapeutic targets for the treatment of severe influenza pneumonia without affecting host anti-viral defence through suppressing macrophage cytokine/chemokine production.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据